Ilja Spellmann
Impact in
- Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 37
-
- Treatment of Major Depression 5
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Michael J Riedel (33 shared papers)Norbert Müller (24 shared papers)Sandra Dehning (21 shared papers)Markus Schwarz (10 shared papers)Anja Cerovecki (11 shared papers)H.‐J. Möller (6 shared papers)Volker Arolt (3 shared papers)Nikolaus Kleindienst (3 shared papers)
- Journals
- European Archives of Psychiatry and Clinical Neuroscience (13 papers)Journal of Psychiatric Research (4 papers)Pharmacopsychiatry (4 papers)Psychiatry Research (3 papers)European Neuropsychopharmacology (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Ilja Spellmann
46 papers receiving 1.8k citations
Ilja Spellmann's Hit Papers
Peers
Comparison fields: 5 of 93
- Biological Psychiatry 508
- Psychiatry and Mental health 710
- Behavioral Neuroscience 72
- Pharmacology 293
- Pharmacology 104
Countries citing papers authored by Ilja Spellmann
This map shows the geographic impact of Ilja Spellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilja Spellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilja Spellmann more than expected).
Fields of papers citing papers by Ilja Spellmann
This network shows the impact of papers produced by Ilja Spellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilja Spellmann. The network helps show where Ilja Spellmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilja Spellmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Hit paper breakdown → | 2006 | 689 |
| 2 | 2004 | 114 | |
| 3 | 2011 | 111 | |
| 4 | 2005 | 71 | |
| 5 | 2007 | 68 | |
| 6 | 2006 | 62 | |
| 7 | 2006 | 57 | |
| 8 | 2010 | 54 | |
| 9 | 2005 | 51 | |
| 10 | 2007 | 44 | |
| 11 | 2007 | 43 | |
| 12 | 2009 | 43 | |
| 13 | 2010 | 43 | |
| 14 | 2017 | 43 | |
| 15 | 2009 | 37 | |
| 16 | 2012 | 36 | |
| 17 | 2008 | 32 | |
| 18 | 2014 | 32 | |
| 19 | 2008 | 30 | |
| 20 | 2006 | 28 |
About Ilja Spellmann
Ilja Spellmann is a scholar working on Psychiatry and Mental health, Pharmacology, Biological Psychiatry, Pharmacology and Experimental and Cognitive Psychology, having authored 49 papers that have together received 1.9k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (37 papers), Treatment of Major Depression (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Tryptophan and brain disorders (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Macrophage Migration Inhibitory Factor (1 paper) and Mental Health Research Topics (1 paper). The work is most often cited by research in Biological Psychiatry (508 citations), Psychiatry and Mental health (710 citations), Behavioral Neuroscience (72 citations), Pharmacology (293 citations) and Pharmacology (104 citations). Ilja Spellmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Michael J Riedel, Norbert Müller, Sandra Dehning, Markus Schwarz, Anja Cerovecki, H.‐J. Möller, Volker Arolt, Nikolaus Kleindienst, Richard Musil and Katja Maino. Their work appears in journals such as European Archives of Psychiatry and Clinical Neuroscience, Journal of Psychiatric Research, Pharmacopsychiatry, Psychiatry Research and European Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.